Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Flolan 1.5 mg Powder and Solvent for Solution for Infusion (with pH 12 solvent & Vented Vial Adaptor)

Active Ingredient:
epoprostenol sodium
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
B01AC09
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Safety Alert
{arrow_left}
{arrow_right}
Product Information:

Glaxo Wellcome UK Ltd (GSK) has informed of a class 2 Medicines Recall impacting Flolan 1.5mg Powder and Solvent for infusion,

For more information, please refer to full text on MHRA website:

Class 2 Medicines Recall: Glaxo Wellcome UK Limited (trading as GlaxoSmithKline UK), Flolan 1.5 mg Powder and Solvent for Solution for Infusion, EL(24)A/30 - GOV.UK (www.gov.uk)
GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]